Our Common Welfare

Our Common Welfare (OCW) is a non-profit biotechnology company dedicated to developing and delivering affordable medicines for diseases that disproportionately affect underserved populations globally. Founded by industry veterans and academic leaders, including the late Tachi Yamada and Sangeeta Bhatia, the organization operates as a social enterprise to bridge the gap between academic discovery and large-scale pharmaceutical production. OCW focuses on high-impact areas such as tuberculosis, malaria, and other neglected tropical diseases, leveraging partnerships with both academic institutions and commercial pharmaceutical companies to ensure equitable access to life-saving therapies. The company utilizes advanced drug development tools and a unique funding model to advance candidates through the clinical pipeline. By operating as a non-profit, OCW can prioritize global health impact over financial returns, aiming to provide high-quality treatments at the lowest possible cost.